Latest News of KZIA
Kazia Therapeutics Limited (KZIA) Stock Price, News, Quote & History
By Yahoo! Finance |
2 months ago
Kazia Therapeutics Limited, an oncology-focused biotech company, is developing Paxalisib for glioblastoma and EVT801 for vascular endothelial growth factor receptor 3. Established in 1994 in Sydney, A...